Literature DB >> 29903537

Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica.

Diana Prieto-Peña1, Isabel Martínez-Rodríguez2, Javier Loricera1, Ignacio Banzo2, Mónica Calderón-Goercke1, Vanesa Calvo-Río1, Carmen González-Vela3, Alfonso Corrales1, Santos Castañeda4, Ricardo Blanco1, José L Hernández5, Miguel Á González-Gay6.   

Abstract

OBJECTIVE: Polymyalgia rheumatica (PMR) is often the presenting manifestation of giant cell arteritis (GCA). Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) scan often discloses the presence of large vessel vasculitis (LVV) in PMR patients. We aimed to identify predictive factors of a positive PET/CT scan for LVV in patients classified as having isolated PMR according to well-established criteria.
METHODS: A set of consecutive patients with PMR from a single hospital were assessed. All of them underwent PET/CT scan between January 2010 and February 2018 based on clinical considerations. Patients with PMR associated to other diseases, including those with cranial features of GCA, were excluded. The remaining patients were categorized in classic PMR (if fulfilled the 2012 EULAR/ACR classification criteria at disease diagnosis; n = 84) or atypical PMR (who did not fulfill these criteria; n = 16). Only information on patients with classic PMR was assessed.
RESULTS: The mean age of the 84 patients (51 women) with classic PMR was 71.4 ± 9.2 years. A PET/CT scan was positive in 51 (60.7%). Persistence of classic PMR symptoms was the most common reason to perform a PET/CT scan. Nevertheless, patients with positive PET/CT scan often had unusual symptoms. The best set of predictors of a positive PET/CT scan were bilateral diffuse lower limb pain (OR = 8.8, 95% CI: 1.7-46.3; p = 0.01), pelvic girdle pain (OR = 4.9, 95% CI: 1.50-16.53; p = 0.01) and inflammatory low back pain (OR = 4.7, 95% CI: 1.03-21.5; p = 0.04).
CONCLUSION: Inflammatory low back pain, pelvic girdle and diffuse lower limb pain are predictors of positive PET/CT scan for LVV in PMR.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Giant cell arteritis; Large vessel vasculitis; PET/CT scan; Polymyalgia rheumatica; Predictors

Mesh:

Substances:

Year:  2018        PMID: 29903537     DOI: 10.1016/j.semarthrit.2018.05.007

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  10 in total

Review 1.  [Granulomatous vasculitides and vasculitides with extravascular granulomatosis].

Authors:  Sabrina Arnold; Sebastian Klapa; Konstanze Holl-Ulrich; Antje Müller; Anja Kerstein-Stähle; Peter Lamprecht
Journal:  Z Rheumatol       Date:  2022-08-12       Impact factor: 1.530

Review 2.  Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.

Authors:  Dario Camellino; Eric L Matteson; Frank Buttgereit; Christian Dejaco
Journal:  Nat Rev Rheumatol       Date:  2020-08-05       Impact factor: 20.543

Review 3.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

4.  The Role of Vascular Imaging to Advance Clinical Care and Research in Large-Vessel Vasculitis.

Authors:  Kaitlin A Quinn; Peter C Grayson
Journal:  Curr Treatm Opt Rheumatol       Date:  2019-02-09

Review 5.  Giant cell arteritis: is the clinical spectrum of the disease changing?

Authors:  Miguel Á González-Gay; Miguel Ortego-Jurado; Liliana Ercole; Norberto Ortego-Centeno
Journal:  BMC Geriatr       Date:  2019-07-29       Impact factor: 3.921

Review 6.  The Immunopathology of Giant Cell Arteritis Across Disease Spectra.

Authors:  Michelle L Robinette; Deepak A Rao; Paul A Monach
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 7.  A Review of the Dermatological Complications of Giant Cell Arteritis.

Authors:  Diana Prieto-Peña; Santos Castañeda; Belén Atienza-Mateo; Ricardo Blanco; Miguel Ángel González-Gay
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-03-25

8.  Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status.

Authors:  Attila Hamar; Zsolt Hascsi; Anita Pusztai; Monika Czókolyová; Edit Végh; Zsófia Pethő; Katalin Gulyás; Boglárka Soós; György Kerekes; Éva Szekanecz; Katalin Hodosi; Sándor Szántó; Gabriella Szűcs; Tamás Seres; Zoltán Szekanecz; Szilvia Szamosi
Journal:  RMD Open       Date:  2021-11

9.  Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica (PMR): A Retrospective Comparison Study between Hospital and Out-of-Hospital Local Registries.

Authors:  Ciro Manzo; Marcin Milchert; Carlo Venditti; Alberto Castagna; Arvind Nune; Maria Natale; Marek Brzosko
Journal:  Life (Basel)       Date:  2022-06-30

10.  Large-vessel involvement is predictive of multiple relapses in giant cell arteritis.

Authors:  Donatienne de Mornac; Olivier Espitia; Antoine Néel; Jérôme Connault; Agathe Masseau; Alexandra Espitia-Thibault; Mathieu Artifoni; Aurélie Achille; Anaïs Wahbi; Mathieu Lacou; Cécile Durant; Pierre Pottier; François Perrin; Julie Graveleau; Mohamed Hamidou; Jean-Benoit Hardouin; Christian Agard
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-05-18       Impact factor: 5.346

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.